Inventor profile of:

E. Itzhak LERNER

City:

Petach Tikva

Country:

Israel

Published Applications:

35

Last publication date:

2016-10-13

Top Assignees for applications by E. Itzhak LERNER

The entities that hold a legal rights for patent applications filed by inventor LERNER E. Itzhak:

Recent patent applications by LERNER E. Itzhak

E. Itzhak LERNER from Petach Tikva, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-10-13
US20160296473A1
Human necessities

Formulations of 6-mercaptopurine

#2 | 2015-10-15
US20150290133A1
Human necessities

Formulations of 6-mercaptopurine

#3 | 2014-06-12
US20140161888A1
Human necessities

Formulations of 6-mercaptopurine

#4 | 2014-05-15
US20140134256A1
Human necessities

Risperidone microparticles formed by sublimation

#5 | 2012-08-16
US20120207841A1
Human necessities

Formulations of 6-mercaptopurine

#6 | 2010-11-04
US20100278912A1
Human necessities

Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition

#7 | 2010-04-15
US20100092568A1
Human necessities

Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them

#8 | 2010-03-09
US9887204
-

Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition

#9 | 2009-11-03
US10419536
-

Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it

#10 | 2009-02-12
US20090042914A1
Human necessities

Delayed release formulations of 6-mercaptopurine

#11 | 2008-03-06
US20080057129A1
Human necessities

Drug microparticles

#12 | 2007-08-02
US20070178149A1
Human necessities

Levodopa compositions

#13 | 2007-06-28
US20070148233A1
Human necessities

Pharmaceutical formulations of fenofibrate having improved bioavailability

#14 | 2007-03-27
US10191298
-

Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery

#15 | 2007-01-18
US20070015834A1
Human necessities

Formulations of fenofibrate containing PEG/Poloxamer

#16 | 2007-01-18
US20070015833A1
Human necessities

Formulations of fenofibrate containing menthol

#17 | 2006-10-19
US20060233880A1
Human necessities

Controlled release dosage forms

#18 | 2006-10-19
US20060233879A1
Human necessities

Controlled released dosage forms

#19 | 2006-10-05
US20060222707A1
Human necessities

Formulations of fenofibrate

#20 | 2006-10-05
US20060222706A1
Human necessities

Formulations of Fenofibrate

#21 | 2006-07-13
US20060153918A1
Human necessities

Dosage forms with an enterically coated core tablet

#22 | 2006-06-29
US20060141052A1
Human necessities

Drug microparticles

#23 | 2006-06-29
US20060141051A1
Human necessities

Drug microparticles

#24 | 2006-06-29
US20060141028A1
Human necessities

Cyclosporin formulations

#25 | 2006-01-26
US20060018957A1
Human necessities

Pharmaceutical dosage forms including rasagiline

#26 | 2006-01-12
US20060009473A1
Human necessities

Formulations of 6-mercaptopurine

#27 | 2006-01-12
US20060008520A1
Human necessities

Delayed release formulations of 6-mercaptopurine

#28 | 2005-12-22
US20050282784A1
Human necessities

Therapy using a combination of raloxifene and alendronate

#29 | 2005-09-01
US20050192340A1
Human necessities

Simvastatin formulations and methods of making same

#30 | 2005-08-04
US20050170004A1
Human necessities

Nanoparticles for drug delivery

#31 | 2005-05-26
US20050113452A1
Human necessities

Composition and dosage form for sustained effect of levodopa

#32 | 2005-05-26
US20050112202A1
Human necessities

Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it

#33 | 2005-04-19
US10026573
-

Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation

#34 | 2005-03-03
US20050048086A1
Human necessities

Compositions and dosage forms for gasteric delivery of antineoplastic agents and methods of treatment that use them to inhibit cancer cell proliferation

#35 | 2005-02-03
US20050026871A1
Human necessities

Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative

InventorID:

762077 ⎘